HCW Biologics Inc. (HCWB) vs Sunshine Biopharma, Inc. (SBFM)
A side-by-side comparison of HCW Biologics Inc. and Sunshine Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HCWB
HCW Biologics Inc.
$1.61HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
SBFM
Sunshine Biopharma, Inc.
$0.37HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — HCWB vs SBFM
growth of $100 · dividends reinvested · last 5yHCWB -99.7% (-68.8%/yr)SBFM -100.0% (-87.3%/yr)HCWB compounded faster over this window
Log scale — wide-divergence pair
HCWB SBFM
HCWB vs SBFM: by the numbers
- •SBFM is the larger company ($880215 vs $559702 market cap).
- •Both run net losses; SBFM's is the smaller (-16.50% vs -73.22% net margin).
- •SBFM grew revenue faster over the past five years (203.18% vs -57.90% CAGR).
Metrics side by side
Valuation
| Metric | HCWB | SBFM |
|---|---|---|
| P/S ratio | 0.08 | 0.02 |
| P/B ratio | 0.08 | 0.03 |
Profitability
| Metric | HCWB | SBFM |
|---|---|---|
| Gross margin | 20.00% | 29.80% |
| Operating margin | -20757.65% | -14.71% |
| Net margin | -73.22% | -16.50% |
| ROE | -66.26% | -21.18% |
| ROIC | -41.92% | -18.56% |
Growth (annualized)
| Metric | HCWB | SBFM |
|---|---|---|
| Revenue CAGR (5Y) | -57.90% | 203.18% |
| Total return CAGR (5Y) | -69.71% | N/A |
Frequently asked
- Which has grown faster, HCWB or SBFM?
- Over the past five years, SBFM grew revenue faster — HCWB at a -57.90% CAGR versus SBFM at 203.18%.
Go deeper
Dig into the metrics
HCW Biologics ROESunshine Biopharma ROEHCW Biologics operating marginSunshine Biopharma operating marginHCW Biologics revenue growthSunshine Biopharma revenue growthHCW Biologics free cash flowSunshine Biopharma free cash flow
HCW Biologics & Sunshine Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.